Hosaka N, Ichikawa Y, Ishikawa T, Nagashima Y, Kunisaki C, Takahashi M, Moriwaki Y, Akiyama H, Yamaguchi S, Ota M, Ooki S, Ike H, Shimada H
Second Department of Surgery and Department of Pathology, Yokohama City University, School of Medicine, 3-9 Fukuura Kanazawa-ku, Yokohama, Japan.
Anticancer Res. 2001 Jan-Feb;21(1A):229-35.
To determine whether the expression of p53, p21, bcl-2 or Ki-67 in cancer cells is predictive of chemosensitivity, immunohistochemical examination of these factors and chemosensitivity assays were performed on colon and gastric cancer specimens. Chemosensitivity tests were performed using CDDP, 5-FU, MMC, or ADR and inhibition rate (IR) was calculated by MTT assay. Before exposure to anticancer drugs, the samples were investigated immunohistochemically for expression of the above factors and after anticancer drug exposure by TUNNEL staining, for the presence of apoptotic cells. With 5-FU and MMC, the apoptotic index was well correlated with IR, so their effects were related to apoptosis. Moreover, with these two agents, the p53 labeling index (LI) was inversely correlated with IR and p21-LI showed a good correlation with IR. We therefore concluded that immunohistochemical studies for p53 and p21 were useful for predicting the chemosensitivities of colon and gastric cancer to MMC and 5-FU.
为了确定癌细胞中p53、p21、bcl-2或Ki-67的表达是否可预测化疗敏感性,对结肠癌和胃癌标本进行了这些因子的免疫组化检查及化疗敏感性检测。使用顺铂(CDDP)、5-氟尿嘧啶(5-FU)、丝裂霉素(MMC)或阿霉素(ADR)进行化疗敏感性测试,并通过MTT法计算抑制率(IR)。在接触抗癌药物之前,通过免疫组化研究上述因子的表达,在接触抗癌药物之后,通过TUNNEL染色检测凋亡细胞的存在。对于5-FU和MMC,凋亡指数与IR密切相关,因此它们的作用与凋亡有关。此外,对于这两种药物,p53标记指数(LI)与IR呈负相关,p21-LI与IR呈良好的相关性。因此,我们得出结论,p53和p21的免疫组化研究有助于预测结肠癌和胃癌对MMC和5-FU的化疗敏感性。